On April 10, 2026, Gregory George, a Director and 10% Owner of Mesoblast Ltd. (MESO), executed a series of significant share purchases. In total, Mr. George acquired approximately 7,210,962 shares across multiple transactions, with a combined value of roughly $10.39 million.
The purchases were made at prices ranging from $1.42 to $1.48 per share. This cluster buying activity, where multiple insiders purchase shares within a similar timeframe, is often interpreted as a strong bullish signal by market observers.
Mesoblast Ltd. is a regenerative medicine company. The substantial investment by a key insider like Mr. George may indicate a heightened level of confidence in the company's future prospects.